Victoria S. Blinder

TL;DR: The authors discuss the nature of financial toxicity, defined as the objective financial burden and subjective financial distress of patients with cancer, as a result of treatments using innovative drugs and concomitant health services, and management strategies for oncologists.

TL;DR: This data indicates that cancer and its treatment lead to increased financial distress for patients, and no standardized patient‐reported outcome measure has been validated to assess this distress.

TL;DR: The Society calls for increased outreach and educational support for SGM patients; increased SGM cultural competency training for providers; improvement of quality-of-care metrics that include sexual orientation and gender information variables; and increased data collection to inform future work addressing the needs of SGM communities.

TL;DR: There are compelling reasons to conduct studies of cancer in Hispanics, the fastest growing major demographic group in the United States, and there have been no studies of Hispanics reported to date.

TL;DR: The trajectories of low‐income Latina and non‐Latina white survivors are compared and correlates of employment status are identified to identify correlates of Employment status.